Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Everything Else, Sold Out, 2016 Q3, Page 5

CITADEL ADVISORS LLC historic quarter change: USA Everything Else, Sold out

In partnership units, exchange-traded notes and anything else (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 11,824 positions, added to 16,498, reduced 15,969 and sold out of 13,072.

  • Q3 2016: Stock ORAGENICS INC COMMON STOCK; Country of operation —; Class Cmn; Shares before 33,983.
  • Q3 2016: Stock AMPLIPHI BIOSCIENCES CORP; Country of operation —; Class Cmn; Shares before 10,478.
  • Q3 2016: Stock DXI ENERGY INC; Country of operation —; Class Cmn; Shares before 126,207.
  • Q3 2016: Stock ZHONE TECHNOLOGIES INC COMMON STOCK; Country of operation —; Class Cmn; Shares before 12,779.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016ORAGENICS INC COMMON STOCK
CUSIP 684023203
—Cmn33,9830-33,983$17$0-$172016-11-10
Q3 2016AMPLIPHI BIOSCIENCES CORP
CUSIP 03211P202
—Cmn10,4780-10,478$16$0-$162016-11-10
Q3 2016DXI ENERGY INC
CUSIP 23286A104
—Cmn126,2070-126,207$16$0-$162016-11-10
Q3 2016ZHONE TECHNOLOGIES INC COMMON STOCK
CUSIP 98950P884
—Cmn12,7790-12,779$15$0-$152016-11-10
Q3 2016CHANTICLEER HOLDINGS INC COMMON STOCK
CUSIP 15930P404
—Cmn34,8510-34,851$15$0-$152016-11-10
Q3 2016ONCOTHERA PHARMACEUTICALS INC COMMON STOCK
CUSIP 15117N404
—Cmn10,8660-10,866$14$0-$142016-11-10
Q3 2016FEMALE HEALTH CO CMN STK
CUSIP 314462102
—Cmn10,0670-10,067$13$0-$132016-11-10
Q3 2016INSTITUTIONAL FINANCIAL MARKET
CUSIP 45779L107
—Cmn15,4210-15,421$13$0-$132016-11-10
Q3 2016BIND THERAPEUTICS INC
CUSIP 05548N107
—Cmn32,6200-32,620$13$0-$132016-11-10
Q3 2016SEQUENOM INC CMN STOCK
CUSIP 817337405
—Cmn12,8700-12,870$12$0-$122016-11-10
Q3 2016PHOTOMEDEX INC CMN STOCK
CUSIP 719358301
—Cmn48,8330-48,833$12$0-$122016-11-10
Q3 2016PEREGRINE PHARMACEUTICALS INC COMMON STOCK
CUSIP 713661304
—Cmn29,5860-29,586$11$0-$112016-11-10
Q3 2016CHINANET ONLINE HOLDINGS INC
CUSIP 16949H102
—Cmn18,2550-18,255$10$0-$102016-11-10
Q3 2016IMMUNOCELLULAR THERAPEUTICS CMN STK
CUSIP 452536105
—Cmn42,0420-42,042$10$0-$102016-11-10
Q3 2016FUNCTIONX INC
CUSIP 36077T108
—Cmn32,3270-32,327$9$0-$92016-11-10
Q3 2016BIOPHARMX CORP
CUSIP 09072X101
—Cmn13,6680-13,668$9$0-$92016-11-10
Q3 2016TOWERSTREAM CORP COMMON STOCK
CUSIP 892000100
—Cmn48,4980-48,498$8$0-$82016-11-10
Q3 2016PROTALIX BIOTHERAPEUTICS INC CMN STOCK
CUSIP 74365A101
—Cmn10,6830-10,683$7$0-$72016-11-10
Q3 2016INFINITY CROSS BORDER ACQUIS
CUSIP 379606106
—Cmn28,5950-28,595$6$0-$62016-11-10
Q3 2016CALADRIUS BIOSCIENCES INC
CUSIP 128058104
—Cmn10,8180-10,818$6$0-$62016-11-10
Q3 2016HEMISPHERX BIOPHARMA INC CMN STOCK
CUSIP 42366C103
—Cmn45,7880-45,788$5$0-$52016-11-10
Q3 2016PROFESSIONAL DIVERSITY NETWO
CUSIP 74312Y103
—Cmn12,3420-12,342$5$0-$52016-11-10
Q3 2016SAEXPLORATION HOLDINGS INC
CUSIP 78636X105
—Cmn36,5270-36,527$4$0-$42016-11-10
Q3 2016NEURALSTEM INC COMMON STOCK
CUSIP 64127R302
—Cmn11,2890-11,289$3$0-$32016-11-10

Similar Firms

Firm NameCountry13F ValueHoldings
Capital Research Global InvestorsUnited States$644.560B459
Invesco Ltd.United States$653.294B23,552
CHARLES SCHWAB INVESTMENT MANAGEMENT INCUnited States$654.473B3,645
UBS Group AGSwitzerland$666.317B22,771
ROYAL BANK OF CANADACanada$570.144B25,608
Bank of New York Mellon CorpUnited States$543.906B33,728
WELLINGTON MANAGEMENT GROUP LLPUnited States$535.463B7,458
WELLS FARGO & COMPANY/MNUnited States$530.336B17,971
Capital World InvestorsUnited States$732.940B620
DIMENSIONAL FUND ADVISORS LPUnited States$481.393B13,635